In recent years BMY has lacked discipline. BMY’s refusal to raise bid for IMCL (Imclone) shows that the much talked about change has finally taken hold. Consider scaling in low $19 range and add if the stock dips. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD
Our methodology calls for adding aggressively to our PPC position right here at $2.86 www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the
PPC is down to $4.29 on announcement of major loss and non-compliance with debt covenants. We believe nothing material from longer term perspective has changed for PPC. Our analysis indicates that new agreement with lenders is likely. We had expected a loss double the street consensus of $0.86 due to
On Sept 16,2008 we recommended considering buying BAC. We bought at $22. Our thesis for buying remains intact. However, in view of out sized gains in just three days, we exited at $38.83 on Sept 19 right after the open. Those still holing BAC should consider selling 75% of the
We hit bulls eye by informing you before it was generally known that the bailouut will not cover non US institutions and providing you with the oppotunity to exit BCS position with over 30% profit in three days. Following is the text of the Treasury plan: September 20, 2008, 1:05
On Sept 16, 2008 we recommended buying BCS due to their buying Lehman assets on the cheap. In three days, we have profits from buying at $22 to the after hours price of $ 29-30. Our sources inform us that US government plan to buy illiquid assets will not be
Strategic value of MER outweigh potential loses from MER balance sheet. BAC has traditionally done a good job at integrating acquisitions, but MER is a different animal than traditional commercial bank acquisitions. However, our review shows that more likely than not MER will be successfully integrated in BAC and strategic
We believe BCS purchase of Lehman assets in bankruptcy is a coup. This is a major change as it will significantly increase BCS presence in US. The current financial crises will pass and the assets bought cheap will pay rich dividends. Consider scaling in in $22-23 range and add on
After the close, Samsung announced $26 cash bid for SNDK. The offer is not contingent on financing. We believe there is a distinct possibility of a competing bod from Toshiba. On the other hand there is some antitrust risk in Samsung bid. On balance, we believe it is advantageous to
Recently, we warned against shorting SNDK and recommended buying SNDK around $13 due to possibility of a buy out. Today Korea’s ETimes reports that Samsung may be considering buying SNDK. Our sources indicate that report is true. Moreover, it makes sense. In keeping with our methodology to lock in profits